top of page
Arstat Pharmaceuticals
Advancing Transformational Products for Tens of Millions of Women
Our Portfolio
One of the Best Portfolios in Women’s Health
Twelve US Patents, two Phase III-ready products,
two potential blockbusters
TM
The first and only
contraceptive endorsed by the FDA for exclusive testing and labeling for women with overweight and obesity
(≈20 million US contraceptive users)
Addressing a high public health priority in the post-Roe world
TM
First-in-category
medicated vaginal ring for uterine fibroids and endometriosis
(>15 million US women)
Designed to drastically reduce the need for radical surgeries
TM
First-in-category
single non-hormonal therapy for painful, heavy menstrual periods
(>25 million US women)
A potential treatment of choice for a common menstrual disorder
Mission
Develop Safe and Effective Solutions for Highly Prevalent, Under-treated Reproductive Conditions and Disorders
​
Contact Us
bottom of page